-
Molbio Diagnosti
1,393.10 925.80(%) -
Pine Labs
206.10 283.70(%) -
Larsen & Toubro
3,880.55 3,288.65(%) -
HDFC Bank
708.90 1,020.35(%) -
Power Grid Corpn
268.30 250.05(%) -
ESDS Software
1,716.35 1,716.35(%) -
Trent
2,815.00 3,497.35(%) -
Raymond
1,024.00 1,024.00(%) -
Metro Brands
924.20 883.40(%) -
Reliance Industries
1,253.20 1,250.55(%) -
Billionbrains
200.90 227.00(%) -
Ather Energy
1,615.00 530.65(%) -
One 97
1,829.50 1,829.50(%) -
Hind.Aeronautics
4,861.65 3,479.20(%) -
UPL
567.25 558.00(%) -
HDFC Life Insur.
531.15 796.60(%) -
Bajaj Finance
1,015.40 788.40(%) -
Lodha Developers
1,076.00 650.85(%) -
Dhoot Transmission
1,727.35 1,727.35(%) -
Britannia Inds.
4,946.05 4,946.05(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Jagran Prakashan Ltd Entertainment / Electronic Media Software
- Indian Private
- BSE Code : 22118.0
- ISIN : INE199G01027
-
Today’s Low
61.50 -
Today’s High
62.56
-
Open
62.02 -
Perv Close
62.01 -
52W Low
59.50 -
52W High
78.90
Key Indicators
-
P/E(TTM)
6.15
-
Mar.Cap (₹Cr.)
1,351.42
-
Div & Yield %
16.12
-
Book Value(₹)
82.76
-
Debt-Equity Ratio
0.13
-
AGM Date
11-Sep-2026
-
EPS
10.09
-
P/E Ratio
6.15
Financials Ratios
-
Debt-Equity Ratio
0.13
-
Mar.Cap (₹Cr.)
1,351.42
-
RONW (%)
7.66
-
ROCE (%)
9.77
Score Board
-
Equity (₹ in Cr.)
43.53
-
BV (₹)
82.80
-
Sales( ₹ in Cr.)
1,647.24
-
NP (in Cr.)
223.21
-
NP Var(%)
20.0
-
Div%
500.0
-
CPS (₹)
12.80
-
EPS (₹)
10.30
-
Traded Value (₹ in Lakhs)
1,350.54
-
52 Week High
78.90
-
52 Week Low
59.50
-
Price BSE
62.0
-
Price NSE
62.00
-
Market Capital( in Cr.)
1,350.54
-
P/C Ratio
4.90
-
P/E Ratio
6.00
-
Price Vs.BV
10.30
-
12-Aug-2026( 07:06)
Results - Announcements - Jagra... - Jagran Prakashan Ltd share pri...
-
03-Aug-2026( 07:01)
Corporate News - Jagra... - Jagran Prakashan Limited will...
-
21-Jul-2026( 09:36)
Corporate News - Jagra... - Jagran Prakashan will hold a m...
-
05-Jun-2026( 02:45)
Hot Pursuit - Jagra... - <p>Suven Life Sciences Ltd, Ra...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)| Particulars(INCOME) | 2026 Mar | 2025 Mar | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar |
|---|---|---|---|---|---|---|
| INCOME : | ||||||
| Sales Turnover | 1,647.24 | 1,589.84 | 1,640.67 | 1,593.90 | 1,401.23 | 1,133.37 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 1,647.24 | 1,589.84 | 1,640.67 | 1,593.90 | 1,401.23 | 1,133.37 |
| Other Income | 97.58 | 76.77 | 65.07 | 85.03 | 55.89 | 66.13 |
| Stock Adjustments | 0.00 | 0.00 | 0.00 | -0.04 | 0.00 | 0.03 |
| Total Income | 1,744.82 | 1,666.61 | 1,705.74 | 1,678.89 | 1,457.12 | 1,199.53 |
| EXPENDITURE : | ||||||
| Raw Materials | 415.77 | 406.85 | 470.24 | 539.29 | 408.59 | 300.24 |
| Power and Fuel Cost | 28.31 | 27.51 | 26.68 | 25.34 | 25.34 | 24.54 |
| Employee Cost | 348.33 | 329.99 | 310.23 | 297.85 | 288.16 | 296.31 |
| Other Manufacturing Expenses | 394.36 | 375.64 | 336.28 | 83.38 | 67.08 | 62.41 |
| Selling and Administration Expenses | 118.39 | 114.58 | 100.13 | 291.92 | 194.30 | 142.69 |
| Miscellaneous Expenses | 69.26 | 62.61 | 67.18 | 60.18 | 60.96 | 92.24 |
| Employee Benefit Expenses | 348.33 | 329.99 | 310.23 | 297.85 | 288.16 | 296.31 |
| Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Expenses | 1,374.42 | 1,317.18 | 1,310.75 | 1,297.97 | 1,044.42 | 918.43 |
| Operating Profit | 370.40 | 349.43 | 395.00 | 380.92 | 412.70 | 281.10 |
| Interest | 9.11 | 8.86 | 16.28 | 33.27 | 27.61 | 28.33 |
| Gross Profit | 361.29 | 340.57 | 378.72 | 347.65 | 385.09 | 252.77 |
| Depreciation | 54.49 | 52.73 | 53.32 | 49.08 | 60.16 | 68.57 |
| Profit Before Tax | 306.80 | 287.84 | 325.40 | 298.57 | 324.93 | 184.20 |
| Current Tax | 64.01 | 68.14 | 67.28 | 67.71 | 84.31 | 65.81 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 5.37 | 8.58 | 13.60 | 2.17 | -7.72 | -17.15 |
| Reported Net Profit | 237.41 | 211.12 | 244.52 | 228.68 | 248.34 | 135.53 |
| Extraordinary Items | 14.20 | 25.61 | 25.07 | 31.58 | 11.87 | 13.64 |
| Adjusted Net Profit | 223.21 | 185.51 | 219.45 | 197.10 | 236.47 | 121.89 |
| Adjustment below Net Profit | 1.27 | -2.74 | -2.80 | -414.54 | -81.29 | -13.36 |
| P & L Balance brought forward | 1,482.97 | 1,383.43 | 1,141.71 | 1,442.23 | 1,278.08 | 1,156.50 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 130.59 | 108.83 | 0.00 | 114.66 | 2.91 | 0.60 |
| P & L Balance carried down | 1,591.06 | 1,482.97 | 1,383.43 | 1,141.71 | 1,442.23 | 1,278.08 |
| Dividend | 0.00 | 0.00 | 0.00 | 105.46 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 500.00 | 300.00 | 250.00 | 200.00 | 0.00 | 0.00 |
| Dividend Per Share(Rs) | 10.00 | 6.00 | 5.00 | 4.00 | 0.00 | 0.00 |
| Earnings Per Share-Unit Curr | 10.91 | 9.70 | 11.23 | 10.51 | 9.42 | 4.87 |
| Earnings Per Share(Adj)-Unit Curr | 10.91 | 9.70 | 11.23 | 10.51 | 9.42 | 4.87 |
| Book Value | 82.76 | 77.80 | 73.22 | 62.12 | 62.68 | 53.68 |
| Book Value(Adj)-Unit Curr | 82.76 | 77.80 | 73.22 | 62.12 | 62.68 | 53.68 |
